drugset / Trial / NCT07169773

Comparative Study Between Rezum and Tamsulosin

NCT07169773

Completed 94 enrolled khaled Abdelsattar Gad Ibrahim
RandomizedParallel-groupOpen-labelTreatment

Summary

the investigators aimed to compare the efficacy and safety of Rezūm therapy for the management of benign prostatic hyperplasia (BPH) with Tamsulosin.

Timeline

Start
2022-05-01
Primary completion
2023-05-01
Completion
2023-06-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tamsulosin Other / unclassified